Naoko Ishibe

2.8k total citations · 1 hit paper
28 papers, 2.1k citations indexed

About

Naoko Ishibe is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Naoko Ishibe has authored 28 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Naoko Ishibe's work include Chronic Lymphocytic Leukemia Research (7 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Genetic factors in colorectal cancer (4 papers). Naoko Ishibe is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Genetic factors in colorectal cancer (4 papers). Naoko Ishibe collaborates with scholars based in United States, Chile and Malaysia. Naoko Ishibe's co-authors include Mary L. McMaster, Christina M. Bromley, Dilys M. Parry, Alisa M. Goldstein, Karl T. Kelsey, Lynn R. Goldin, David J. Hunter, Gerald E. Marti, S. Perwez Hussain and William P. Bennett and has published in prestigious journals such as Nature Medicine, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Naoko Ishibe

27 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chordoma: incidence and survival patterns in the United States, 1973–1995

2001 708 citations Mary L. McMaster, Alisa M. Goldstein et al. Cancer Causes & Control profile →

Peers

Countries citing papers authored by Naoko Ishibe

Since Specialization

Citations

This map shows the geographic impact of Naoko Ishibe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Ishibe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Ishibe more than expected).

Fields of papers citing papers by Naoko Ishibe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoko Ishibe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Ishibe. The network helps show where Naoko Ishibe may publish in the future.

Co-authorship network of co-authors of Naoko Ishibe

This figure shows the co-authorship network connecting the top 25 collaborators of Naoko Ishibe. A scholar is included among the top collaborators of Naoko Ishibe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoko Ishibe. Naoko Ishibe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Allostatic load and cancer risk, progression, and mortality in epidemiologic studies 2025 ·American Journal of Epidemiology ·Naoko Ishibe, Gary L. Ellison, (unknown), Tram Kim Lam	0
2	Use of Epidermal Growth Factor Receptor Mutation Analysis in Patients with Advanced Non-Small-Cell Lung Cancer to Determine Erlotinib Use as First-Line Therapy 2011 ·PLoS Currents ·Naoko Ishibe, Josh J. Carlson, Scott D. Ramsey, Andrew N. Freedman, Sheri D. Schully	4
3	Use of Oncotype DX in Women with Node-Positive Breast Cancer 2011 ·PLoS Currents ·Naoko Ishibe, Sheri D. Schully, Andrew N. Freedman, Scott D. Ramsey	14
4	Overview of the Institute of Medicine's Committee Search Strategy and Review Process for Gulf War and Health 2009 ·Journal of Head Trauma Rehabilitation ·Naoko Ishibe, (unknown), (unknown)	18
5	Polymorphisms in Steroid Hormone Pathway Genes and Mammographic Density 2003 ·Breast Cancer Research and Treatment ·Christopher A. Haiman, Susan E. Hankinson, Immaculata De Vivo, Chantal Guillemette, Naoko Ishibe, David J. Hunter, Celia Byrne	70
6	A genome scan of 18 families with chronic lymphocytic leukaemia 2003 ·British Journal of Haematology ·Lynn R. Goldin, Naoko Ishibe, Maria Sgambati, Gerald E. Marti, Laura Fontaine, Maxwell P. Lee, Jenny M. Kelley, (unknown), Kenneth H. Buetow, Neil E. Caporaso	39
7	ATM mutations and protein expression are not associated with familial B-CLL cases 2003 ·Leukemia Research ·Naoko Ishibe, Maria Sgambati, Michael Dean, Lynn R. Goldin, (unknown), Taghi Manshouri, (unknown), Gerald E. Marti, Neil E. Caporaso	8
8	B‐cell monoclonal lymphocytosis and B‐cell abnormalities in the setting of familial B‐cell chronic lymphocytic leukemia 2003 ·Cytometry Part B Clinical Cytometry ·Gerald E. Marti, (unknown), Fatima Abbasi, Glennelle C. Washington, (unknown), Vincent E. Zenger, Naoko Ishibe, Lynn R. Goldin, Laura Fontaine, (unknown), Maria Sgambati, (unknown), Pablo Bertín, Robert F. Vogt, Barbara A. Slade, Philip D. Noguchi, M Stetler-Stevenson, Neil E. Caporaso	104
9	Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas 2002 ·Pharmacogenetics ·Naoko Ishibe, Rashmi Sinha, David W. Hein, Martin Kulldorff, Paul T. Strickland, Adrian J. Fretland, Wong‐Ho Chow, Fred F. Kadlubar, Nicholas P. Lang, Nathaniel Rothman	93
10	Association of prostate cancer with rapid N‐acetyltransferase 1 (NAT110) in combination with slow N‐acetyltransferase 2 acetylator genotypes in a pilot case‐control study 2002 ·Environmental and Molecular Mutagenesis* ·David W. Hein, Matthew A. Leff, Naoko Ishibe, Rashmi Sinha, Harold A. Frazier, Mark A. Doll, Gong Xiao, Martin C. Weinrich, Neil E. Caporaso	51
11	Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. 2002 ·PubMed ·Francine Laden, Naoko Ishibe, Susan E. Hankinson, Mary S. Wolff, Dorota M. Gertig, David J. Hunter, Karl T. Kelsey	97
12	Understanding the Interaction Between Environmental Exposures and Molecular Events in Colorectal Carcinogenesis 2001 ·Cancer Investigation ·Naoko Ishibe, Andrew N. Freedman	10
13	Clinical Characteristics of Familial B-CLL in the National Cancer Institute Familial Registry 2001 ·Leukemia & lymphoma ·Naoko Ishibe, Maria Sgambati, Laura Fontaine, Lynn R. Goldin, (unknown), (unknown), Gerald E. Marti, (unknown)	55
14	Chordoma: incidence and survival patterns in the United States, 1973–1995 breakdown → 2001 ·Cancer Causes & Control ·Mary L. McMaster, Alisa M. Goldstein, Christina M. Bromley, Naoko Ishibe, Dilys M. Parry	708
15	A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. 2000 ·PubMed ·Naoko Ishibe, Meir J. Stampfer, David J. Hunter, Charles H. Hennekens, Karl T. Kelsey	21
16	Psychosocial factors predictingBRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families 2000 ·American Journal of Medical Genetics ·Barbara B. Biesecker, Naoko Ishibe, Donald W. Hadley, Therese R. Giambarresi, Ronald G. Kase, Caryn Lerman, Jeffery P. Struewing	114
17	Expression of p27^Kip1and bcl-2, cigarette smoking, and colorectal cancer risk 2000 ·Biomarkers ·Naoko Ishibe, Andrew N. Freedman, Arthur M. Michalek, Christine A. Iacobuzio–Donahue, Curtis Mettlin, Nicholas J. Petrelli, (unknown), Stanley R. Hamilton	2
18	Clinical features of patients with stage IIIB and IV bronchioloalveolar carcinoma of the lung 1999 ·Cancer ·Oscar S. Breathnach, Naoko Ishibe, John Williams, R. Ilona Linnoila, Neil E. Caporaso, (unknown)	59
19	p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells 1998 ·Nature Medicine ·Stefan Ambs, (unknown), (unknown), William P. Bennett, Naoko Ishibe, S. Perwez Hussain, Edith Tzeng, David A. Geller, Timothy R. Billiar, C C Harris	236
20	Genetic susceptibility to environmental and occupational cancers 1997 ·Cancer Causes & Control ·Naoko Ishibe, Karl T. Kelsey	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact